Sales & Marketing Sponsored 5 forces reshaping pharma commercialisation in 2026 As infrastructure bottlenecks ease and regulatory frameworks mature, pharma's AI adoption is shifting from proof-of-concept to production-grade deployment
Digital Sponsored Axtria Ignite 2025: A VIP roundtable on agentic AI At Axtria Ignite 2025, over 20 pharma senior executives stepped into a VIP roundtable to discuss how best to unlock agentic AI’s tranformative value.
Digital Agentic AI, culture shifts, and commercialisation today: Ant... Hear Anthony Cilento, VP, data science & customer insights, at Bayer, in a post-Axtria Ignite 2025 discussion on the conference and agentic AI.
Digital Partner Content Axtria and Kedaara Capital Announce Strategic $240 Million I... The transaction delivers total liquidity of $240 million, making it one of the largest employee-centric liquidity events in the industry.
Digital Axtria Ignite 2025: Ritesh Mehra talks AI, culture, and comm... At Axtria Ignite 2025, web editor Nicole Raleigh spoke with Ritesh Mehra, CFO, US, at Ferring Pharmaceuticals.
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.